Emerging treatments
Spotlight on ixazomib: potential in the treatment of multiple myeloma. Muz B et al. Drug Des Devel Ther. 2016 Jan 11;10:217-26. doi: 10.2147/DDDT.S93602. eCollection 2016. Immune Checkpoint Blockade in Lymphoid Malignancies. Thanarajasingam G et al, FEBS J. 2016 Jan 25. doi: 10.1111/febs.13668. [Epub ahead of print]. Elotuzumab: First Global Approval. Markham A. Drugs. 2016 Jan 26. [Epub ahead of print]. TAK-228 (formerly MLN0128), an…